We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Improved outcome with immunosuppressive monotherapy after renal transplantation in Schimke-immuno-osseous dysplasia.
- Authors
Lücke, Thomas; Kanzelmeyer, Nele; Baradaran-Heravi, Alireza; Boerkoel, Cornelius F; Burg, Michael; Ehrich, Jochen H H; Pape, Lars
- Abstract
SIOD is a multisystem disorder caused by a mutant chromatin remodelling protein. The main clinical findings are spondyloepiphyseal dysplasia with disproportionate growth restriction, defective cellular immunity, and steroid-resistant nephrotic syndrome secondary to biopsy proven FSGS leading to ESRF. Concerning ESRF, kidney transplantation is the therapy of choice since FSGS does not recur in the graft. However, with respect to the underlying immune disorder and the increased susceptibility to life threatening infections, the question of the optimal immunosuppressive therapy after renal transplantation remains unresolved. Under conventional immunosuppressive regimens some SIOD patients have developed severe disseminated cutaneous papilloma virus infections or EBV associated lymphoproliferative disease. We present several cases of children with SIOD (four of five had SMARCAL1 mutations) and monotherapy maintenance immunosuppression after renal transplantation and compare them with 13 patients from the SIOD registry. We have found that post-renal transplantation immunosuppressive monotherapy results in a good outcome with a reduced number of severe infections. Due to the underlying immunodeficiency in SIOD, limited immunosuppression may be possible without increasing the risk of acute or chronic rejection.
- Publication
Pediatric transplantation, 2009, Vol 13, Issue 4, p482
- ISSN
1399-3046
- Publication type
Journal Article
- DOI
10.1111/j.1399-3046.2008.01013.x